|
1
|
Adams JC and Watt FM: Regulation of
development and differentiation by the extracellular matrix.
Development. 117:1183–1198. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mavrogonatou E, Pratsinis H, Papadopoulou
A, Karamanos NK and Kletsas D: Extracellular matrix alterations in
senescent cells and their significance in tissue homeostasis.
Matrix Biol. 75–76. 27–42. 2019.PubMed/NCBI
|
|
3
|
Chiquet-Ehrismann R and Tucker RP:
Tenascins and the importance of adhesion modulation. Cold Spring
Harb Perspect Biol. 3:a0049602011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsumoto K, Saga Y, Ikemura T, Sakakura T
and Chiquet-Ehrismann R: The distribution of tenascin-X is distinct
and often reciprocal to that of tenascin-C. J Cell Biol.
125:483–493. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liot S, Aubert A, Hervieu V, Kholti NE,
Schalkwijk J, Verrier B, Valcourt U and Lambert E: Loss of
tenascin-X expression during tumor progression: A new pan-cancer
marker. Matrix Biol Plus. 6–7. 1000212020.PubMed/NCBI
|
|
6
|
Valcourt U, Alcaraz LB, Exposito JY,
Lethias C and Bartholin L: Tenascin-X: Beyond the architectural
function. Cell Adh Migr. 9:154–165. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minamitani T, Ikuta T, Saito Y, Takebe G,
Sato M, Sawa H, Nishimura T, Nakamura F, Takahashi K, Ariga H and
Matsumoto K: Modulation of collagen fibrillogenesis by tenascin-X
and type VI collagen. Exp Cell Res. 298:305–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Egging D, van den Berkmortel F, Taylor G,
Bristow J and Schalkwijk J: Interactions of human tenascin-X
domains with dermal extracellular matrix molecules. Arch Dermatol
Res. 298:389–396. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Margaron Y, Bostan L, Exposito JY,
Malbouyres M, Trunfio-Sfarghiu AM, Berthier Y and Lethias C:
Tenascin-X increases the stiffness of collagen gels without
affecting fibrillogenesis. Biophys Chem. 147:87–91. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zweers MC, van Vlijmen-Willems IM, van
Kuppevelt TH, Mecham RP, Steijlen PM, Bristow J and Schalkwijk J:
Deficiency of tenascin-X causes abnormalities in dermal elastic
fiber morphology. J Invest Dermatol. 122:885–891. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Burch GH, Gong Y, Liu W, Dettman RW, Curry
CJ, Smith L, Miller WL and Bristow J: Tenascin-X deficiency is
associated with Ehlers-Danlos syndrome. Nat Genet. 17:104–108.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schalkwijk J, Zweers MC, Steijlen PM, Dean
WB, Taylor G, van Vlijmen IM, van Haren B, Miller WL and Bristow J:
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X
deficiency. N Engl J Med. 345:1167–1175. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malfait F, Francomano C, Byers P, Belmont
J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, et
al: The 2017 international classification of the Ehlers-Danlos
syndromes. Am J Med Genet C Semin Med Genet. 175:8–26. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okuda-Ashitaka E, Kakuchi Y, Kakumoto H,
Yamanishi S, Kamada H, Yoshidu T, Matsukawa S, Ogura N, Uto S,
Minami T, et al: Mechanical allodynia in mice with tenascin-X
deficiency associated with Ehlers-Danlos syndrome. Sci Rep.
10:65692020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kawakami K and Matsumoto K: Behavioral
alterations in mice lacking the gene for tenascin-X. Biol Pharm
Bull. 34:590–593. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ikuta T, Ariga H and Matsumoto K:
Extracellular matrix tenascin-X in combination with vascular
endothelial growth factor B enhances endothelial cell
proliferation. Genes Cells. 5:913–927. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sakai H, Yokota S, Kajitani N, Yoneyama T,
Kawakami K, Yasui Y and Matsumoto KI: A potential contribution of
tenascin-X to blood vessel formation in peripheral nerves. Neurosci
Res. 124:1–7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sumioka T, Iwanishi H, Okada Y, Nidegawa
Y, Miyajima M, Matsumoto KI and Saika S: Loss of tenascin X gene
function impairs injury-induced stromal angiogenesis in mouse
corneas. J Cell Mol Med. 22:948–956. 2018.PubMed/NCBI
|
|
19
|
Matsumoto K, Sato T, Oka S, Orba Y, Sawa
H, Kabayama K, Inokuchi J and Ariga H: Triglyceride accumulation
and altered composition of triglyceride-associated fatty acids in
the skin of tenascin-X-deficient mice. Genes Cells. 9:737–748.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kajitani N, Yamada T, Kawakami K and
Matsumoto KI: TNX deficiency results in bone loss due to an
increase in multinucleated osteoclasts. Biochem Biophys Res Commun.
512:659–664. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsumoto K, Takayama N, Ohnishi J,
Ohnishi E, Shirayoshi Y, Nakatsuji N and Ariga H: Tumour invasion
and metastasis are promoted in mice deficient in tenascin-X. Genes
Cells. 6:1101–1111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsumoto K, Minamitani T, Orba Y, Sato M,
Sawa H and Ariga H: Induction of matrix metalloproteinase-2 by
tenascin-X deficiency is mediated through the c-Jun N-terminal
kinase and protein tyrosine kinase phosphorylation pathway. Exp
Cell Res. 297:404–414. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsumoto KI and Aoki H: The roles of
tenascins in cardiovascular, inflammatory, and heritable connective
tissue diseases. Front Immunol. 11:6097522020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamaguchi S, Kawakami K, Satoh K, Fukunaga
N, Akama K and Matsumoto KI: Suppression of hepatic dysfunction in
tenascin-X-deficient mice fed a high-fat diet. Mol Med Rep.
16:4061–4067. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Piersma B, Bank RA and Boersema M:
Signaling in fibrosis: TGF-β, WNT, and YAP/TAZ converge. Front Med
(Lausanne). 2:592015.PubMed/NCBI
|
|
26
|
Alcaraz LB, Exposito JY, Chuvin N, Pommier
RM, Cluzel C, Martel S, Sentis S, Bartholin L, Lethias C and
Valcourt U: Tenascin-X promotes epithelial-to-mesenchymal
transition by activating latent TGF-β. J Cell Biol. 205:409–428.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mannaerts I, Leite SB, Verhulst S,
Claerhout S, Eysackers N, Thoen LF, Hoorens A, Reynaert H, Halder G
and van Grunsven LA: The hippo pathway effector YAP controls mouse
hepatic stellate cell activation. J Hepatol. 63:679–688. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nguyen-Lefebvre AT, Selzner N, Wrana JL
and Bhat M: The hippo pathway: A master regulator of liver
metabolism, regeneration, and disease. FASEB J. 35:e215702021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen G, Xia B, Fu Q, Huang X, Wang F, Chen
Z and Lv Y: Matrix mechanics as regulatory factors and therapeutic
targets in hepatic fibrosis. Int J Biol Sci. 15:2509–2521. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Schulz JN, Plomann M, Sengle G, Gullberg
D, Krieg T and Eckes B: New developments on skin fibrosis-essential
signals emanating from the extracellular matrix for the control of
myofibroblasts. Matrix Biol. 68–69. 522–532. 2018.PubMed/NCBI
|
|
31
|
Martin K, Pritchett J, Llewellyn J, Mullan
AF, Athwal VS, Dobie R, Harvey E, Zeef L, Farrow S, Streuli C, et
al: PAK proteins and YAP-1 signalling downstream of integrin beta-1
in myofibroblasts promote liver fibrosis. Nat Commun. 7:125022016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Romaine A, Sørensen IW, Zeltz C, Lu N,
Erusappan PM, Melleby AO, Zhang L, Bendiksen B, Robinson EL,
Aronsen JM, et al: Overexpression of integrin α11 induces cardiac
fibrosis in mice. Acta Physiol (Oxf). 222:2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu CQ, Popova SN, Brown ER,
Barsyte-Lovejoy D, Navab R, Shih W, Li M, Lu M, Jurisica I, Penn
LZ, et al: Integrin alpha 11 regulates IGF2 expression in
fibroblasts to enhance tumorigenicity of human non-small-cell lung
cancer cells. Proc Natl Acad Sci USA. 104:11754–11759. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barczyk M, Carracedo S and Gullberg D:
Integrins. Cell Tissue Res. 339:269–280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tiger CF, Fougerousse F, Grundström G,
Velling T and Gullberg D: Alpha11beta1 integrin is a receptor for
interstitial collagens involved in cell migration and collagen
reorganization on mesenchymal nonmuscle cells. Dev Biol.
237:116–129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kasprzycka M, Hammarström C and Haraldsen
G: Tenascins in fibrotic disorders-from bench to bedside. Cell Adh
Migr. 9:83–89. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
El-Karef A, Yoshida T, Gabazza EC,
Nishioka T, Inada H, Sakakura T and Imanaka-Yoshida K: Deficiency
of tenascin-C attenuates liver fibrosis in immune-mediated chronic
hepatitis in mice. J Pathol. 211:86–94. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nishioka T, Onishi K, Shimojo N, Nagano Y,
Matsusaka H, Ikeuchi M, Ide T, Tsutsui H, Hiroe M, Yoshida T and
Imanaka-Yoshida K: Tenascin-C may aggravate left ventricular
remodeling and function after myocardial infarction in mice. Am J
Physiol Heart Circ Physiol. 298:H1072–H1078. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Carey WA, Taylor GD, Dean WB and Bristow
JD: Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis
following murine lung injury. Am J Physiol Lung Cell Mol Physiol.
299:L785–L793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Masamune A, Kikuta K, Watanabe T, Satoh K,
Hirota M, Hamada S and Shimosegawa T: Fibrinogen induces cytokine
and collagen production in pancreatic stellate cells. Gut.
58:550–559. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Craciun FL, Ajay AK, Hoffmann D, Saikumar
J, Fabian SL, Bijol V, Humphreys BD and Vaidya VS: Pharmacological
and genetic depletion of fibrinogen protects from kidney fibrosis.
Am J Physiol Renal Physiol. 307:F471–F484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Aubert A, Mercier-Gouy P, Aguero S,
Berthier L, Liot S, Prigent L, Alcaraz LB, Verrier B, Terreux R,
Moali C, et al: Latent TGF-β activation is a hallmark of the
tenascin family. Front Immunol. 12:6134382021. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Todorovic V and Rifkin DB: LTBPs, more
than just an escort service. J Cell Biochem. 113:410–418. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang WM, Kapyla J, Puranen JS, Knight CG,
Tiger CF, Pentikainen OT, Johnson MS, Farndale RW, Heino J and
Gullberg D: Alpha 11beta 1 integrin recognizes the GFOGER sequence
in interstitial collagens. J Biol Chem. 278:7270–7277. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lethias C, Carisey A, Comte J, Cluzel C
and Exposito JY: A model of tenascin-X integration within the
collagenous network. FEBS Lett. 580:6281–6285. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liu X, Long X, Liu W, Zhao Y, Hayashi T,
Yamato M, Mizuno K, Fujisaki H, Hattori S, Tashiro SI, et al: Type
I collagen induces mesenchymal cell differentiation into
myofibroblasts through YAP-induced TGF-β1 activation. Biochimie.
150:110–130. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Muppala S, Raghunathan VK, Jalilian I,
Thomasy S and Murphy CJ: YAP and TAZ are distinct effectors of
corneal myofibroblast transformation. Exp Eye Res. 180:102–109.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sun KH, Chang Y, Reed NI and Sheppard D:
α-Smooth muscle actin is an inconsistent marker of fibroblasts
responsible for force-dependent TGFβ activation or collagen
production across multiple models of organ fibrosis. Am J Physiol
Lung Cell Mol Physiol. 310:L824–L836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ikuta T, Sogawa N, Ariga H, Ikemura T and
Matsumoto K: Structural analysis of mouse tenascin-X: Evolutionary
aspects of reduplication of FNIII repeats in the tenascin gene
family. Gene. 217:1–13. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Endo T, Ariga H and Matsumoto K: Truncated
form of tenascin-X, XB-S, interacts with mitotic motor kinesin Eg5.
Mol Cell Biochem. 320:53–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
